Search Within

Mona M Sabra

Formats
  1. Journal Article (32)
  2. Meeting Abstract (8)
  3. Editorial (2)
  4. Book Section (1)
Groups
  1. Department of Medicine (43)
  2. Division of Subspecialty Medicine (43)
  3. Endocrinology (43)
  4. Survivorship Research (34)
  5. GSK Faculty (18)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (15)

More Groups

People
  1. Robert Tuttle (34)
  2. Eric Sherman (15)
  3. James Fagin (15)
  4. Ronald Ghossein (15)
  5. Ravinder Grewal (11)
  6. Ashok Shaha (10)

More People

Years
  1. 2025 (1)
  2. 2022 (3)
  3. 2021 (3)
  4. 2020 (2)
  5. 2019 (5)
  6. 2018 (2)

More Years

Publications
  1. Thyroid (14)
  2. International Journal of Radiation Oncology, Biology, Physics (3)
  3. Journal of Clinical Oncology (3)
  4. Cancer (2)
  5. Clinical Nuclear Medicine (2)
  6. Endocrine Practice (2)

More Publications

Publishers
  1. Mary Ann Liebert, Inc (14)
  2. Elsevier Inc. (6)
  3. Wiley Blackwell (5)
  4. American Society of Clinical Oncology (3)
  5. American Association of Clinical Endocrinologists (2)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term results of external beam radiation therapy with or without concurrent chemotherapy in differentiated thyroid cancer
    Journal Article

    Choi, J.; Sherman, E.; Dee, E. C.; Treechairusame, T.; Zakeri, K.; Kang, J. J.; Yu, Y.; Chen, L.; Shamseddine, A.; McBride, S. M.; more...
    Thyroid (2025)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Active surveillance of papillary thyroid cancer: Frequency and time course of the six most common tumor volume kinetic patterns
    Journal Article

    Tuttle, R. M.; Fagin, J.; Minkowitz, G.; Wong, R.; Roman, B.; Patel, S.; Untch, B.; Ganly, I.; Shaha, A.; Shah, J.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ERBB3 monoclonal antibody CDX-3379: Results of a pilot clinical trial
    Journal Article

    Tchekmedyian, V.; Dunn, L.; Sherman, E.; Baxi, S. S.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Postoperative radioactive iodine ablation and treatment of differentiated thyroid cancer
    Book Section

    Sabra, M. M.
    In Randolph, G. W. (Eds.) Surgery of the Thyroid and Parathyroid Glands. 3rd ed (2021)

    Fulltext@MSK | Save
  • Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial
    Journal Article

    Romesser, P. B.; Sherman, E. J.; Whiting, K.; Ho, M. L.; Shaha, A. R.; Sabra, M. M.; Riaz, N.; Waldenberg, T. E.; Sabol, C. R.; Ganly, I.; more...
    Cancer (2021)

    Fulltext@MSK | Save
  • Thyroid cancer and telemedicine during the COVID-19 pandemic
    Editorial

    Chablani, S. V.; Sabra, M. M.
    Journal of the Endocrine Society (2021)

    Fulltext@MSK | Save
  • Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Kriplani, A.; Michel, L. S.; Dunn, L.; Fetten, J. V.; Warner, E.; Grewal, R. K.; Sabra, M.; Tuttle, R. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Structural doubling time predicts overall survival in patients with medullary thyroid cancer in patients with rapidly progressive metastatic medullary thyroid cancer treated with molecular targeted therapies
    Journal Article

    Yeh, T.; Yeung, M.; Sherman, E. J.; Tuttle, R. M.; Sabra, M. M.
    Thyroid (2020)

    Fulltext@MSK | Save
  • Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers
    Journal Article

    Dunn, L. A.; Sherman, E. J.; Baxi, S. S.; Tchekmedyian, V.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Journal of Clinical Endocrinology and Metabolism (2019)

    Fulltext@MSK | Save